How to microdose a Mounjaro pen — and why your prescriber's guidance matters more than the clicks

Mounjaro's KwikPen delivers 2.5 mg per full dose — the device is calibrated and validated for complete, licensed doses only, not fractional clicks.
The 2.5 mg starting dose exists to give your body time to adjust; it is the lowest step in a prescriber-managed titration schedule, not a ceiling to work beneath.
Administering an uncalibrated partial dose risks inaccurate delivery and is not supported by any clinical evidence for weight management.
Any change to your dose, including reducing it, should be discussed with a GPhC-registered prescriber who knows your medical history, not estimated from a click count.

Microdosing a Mounjaro pen means dialling the device below its lowest licensed dose, typically by counting a partial number of clicks rather than completing a full dose. This isn't part of the licensed treatment schedule, and Eli Lilly's KwikPen was not designed or validated for fractional dosing. Mounjaro is a prescription-only medicine; what dose you take, and when you change it, is a decision for your prescriber, not a DIY adjustment made at home. The sections below explain what people searching this query are really asking about, what the risks are, and why the licensed titration schedule exists in the first place.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture on Mounjaro microdosing: what the evidence says and what your prescriber can actually do for you

You've seen the "clicks" method online, here's what's really happening

Perhaps you came across a video or a forum post describing how to deliver less than a full Mounjaro dose by stopping the injection partway through. The logic, as people describe it, is that a smaller amount might reduce side effects while still delivering some benefit. It's an understandable instinct, especially if nausea has made the first few weeks uncomfortable.

The trouble is that Mounjaro's KwikPen is a fixed-dose device. Each full actuation is designed to release 2.5 mg of tirzepatide in a consistent, subcutaneous bolus. If you want to understand how to microdose the Mounjaro KwikPen, it helps to know that stopping the plunger partway does not deliver a reliably measured fraction of that dose; the mechanics of the pen aren't calibrated for partial strokes, so you may inject considerably more or less than you intend. There is no published clinical evidence that this approach produces predictable results, and the NHS tirzepatide guidance makes no mention of it as an accepted technique.

Our prescribers at nume... actually, the prescribers at nume, sorry, this is the kind of thing our clinical team fields regularly. To put it plainly: if you're finding side effects difficult, the answer isn't a homemade dose adjustment; it's a conversation with your prescriber about pausing your titration or staying at 2.5 mg longer.

Why the 2.5 mg starting dose already does exactly what microdosing is supposed to do

The appeal of microdosing usually comes down to two things: tolerability and cost. People either want to ease in more gently than the licensed schedule allows, or they want to stretch a pen further. Both are worth taking seriously.

On tolerability: the licensed schedule already accounts for this. Mounjaro's titration starts at 2.5 mg, a dose that sits at the lower end of the therapeutic range specifically to let the body acclimatise before the prescriber moves upward. If that dose still causes significant nausea or GI discomfort, the correct response is to tell your prescriber. In many cases they will recommend staying at 2.5 mg for longer (eight weeks rather than four, for example) rather than pushing to 5 mg before you're ready. That flexibility is built into the clinical process. You can read more about how the injection itself works in our guide to the Mounjaro injection.

On cost: questions about microdosing the Mounjaro pen often come from people trying to stretch a pen further, but using partial doses compounds the accuracy problem. A single Mounjaro KwikPen contains four full doses. If you're finding the cost difficult to manage, there are legitimate things to discuss with your prescriber, including whether your current dose is the right one and what the treatment plan looks like over time. Our Mounjaro cost page explains what a private prescription typically covers.

What your prescriber can do instead, and when to contact them

If you're searching for how to microdose, you're probably dealing with one of three things: side effects that feel hard to manage, uncertainty about whether the medicine is working, or a wish to feel more in control of the process. All three are conversations a prescriber is well placed to have.

Dose adjustments, including pausing a titration or temporarily reducing a dose, are within a prescriber's scope. What isn't safe is doing that yourself by counting clicks to microdose Mounjaro on a device that wasn't built for it. Incorrect dosing also makes it harder for your prescriber to interpret how you're responding to treatment, if your side effects continue at what you think is half a dose, they won't know whether the dose or something else is the issue.

Urgent symptoms (severe stomach pain that spreads to the back, significant vomiting that leads to dehydration, or signs of an allergic reaction) need medical attention promptly, not a dose change at home. The MHRA's Yellow Card scheme is also there for reporting any unexpected effects.

If you want a clearer picture of the technique for a standard, licensed injection, the step-by-step guide to using the Mounjaro pen walks through the correct process. And if you're thinking about starting treatment or have questions about your current plan, a fresh clinical review is the right place to begin.

Mounjaro is a prescription-only medicine: a prescriber assesses whether it's suitable for you and what dose is appropriate. If you haven't yet started and are wondering how the whole process works, starting a free consultation lets a GPhC-registered prescriber review your situation the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions